These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15556689)

  • 1. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.
    Pizzato N; Derrien M; Lenfant F
    Hum Immunol; 2004 Nov; 65(11):1389-96. PubMed ID: 15556689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
    Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
    J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenously expressed HIV-1 nef down-regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells.
    Shinya E; Owaki A; Shimizu M; Takeuchi J; Kawashima T; Hidaka C; Satomi M; Watari E; Sugita M; Takahashi H
    Virology; 2004 Aug; 326(1):79-89. PubMed ID: 15262497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.
    Williams M; Roeth JF; Kasper MR; Fleis RI; Przybycin CG; Collins KL
    J Virol; 2002 Dec; 76(23):12173-84. PubMed ID: 12414957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two sorting motifs, a ubiquitination motif and a tyrosine motif, are involved in HIV-1 and simian immunodeficiency virus Nef-mediated receptor endocytosis.
    Cai CY; Zhang X; Sinko PJ; Burakoff SJ; Jin YJ
    J Immunol; 2011 May; 186(10):5807-14. PubMed ID: 21482738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
    Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
    Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
    Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
    J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
    Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
    Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses.
    Specht A; DeGottardi MQ; Schindler M; Hahn B; Evans DT; Kirchhoff F
    Virology; 2008 Mar; 373(1):229-37. PubMed ID: 18155264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.
    Greenberg ME; Iafrate AJ; Skowronski J
    EMBO J; 1998 May; 17(10):2777-89. PubMed ID: 9582271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired spontaneous endocytosis of HLA-G.
    Davis DM; Reyburn HT; Pazmany L; Chiu I; Mandelboim O; Strominger JL
    Eur J Immunol; 1997 Oct; 27(10):2714-9. PubMed ID: 9368631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of HIV-1 Nef mutants in the context of viral infection.
    Fackler OT; Moris A; Tibroni N; Giese SI; Glass B; Schwartz O; Kräusslich HG
    Virology; 2006 Aug; 351(2):322-39. PubMed ID: 16684552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.
    Hanna Z; Priceputu E; Hu C; Vincent P; Jolicoeur P
    Virology; 2006 Mar; 346(1):40-52. PubMed ID: 16310238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
    Ali A; Ng HL; Dagarag MD; Yang OO
    Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
    Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
    AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.
    Swigut T; Iafrate AJ; Muench J; Kirchhoff F; Skowronski J
    J Virol; 2000 Jun; 74(12):5691-701. PubMed ID: 10823877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.
    Giese SI; Woerz I; Homann S; Tibroni N; Geyer M; Fackler OT
    Virology; 2006 Nov; 355(2):175-91. PubMed ID: 16916529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
    Carl S; Greenough TC; Krumbiegel M; Greenberg M; Skowronski J; Sullivan JL; Kirchhoff F
    J Virol; 2001 Apr; 75(8):3657-65. PubMed ID: 11264355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.
    van Stigt Thans T; Akko JI; Niehrs A; Garcia-Beltran WF; Richert L; Stürzel CM; Ford CT; Li H; Ochsenbauer C; Kappes JC; Hahn BH; Kirchhoff F; Martrus G; Sauter D; Altfeld M; Hölzemer A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.